Drug Approval | January 25, 2023
Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules
Granules now have a total of 53 ANDA approvals from USFDA
Granules now have a total of 53 ANDA approvals from USFDA
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
APAC to see a reduction in imported surgical robotics
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Subscribe To Our Newsletter & Stay Updated
